Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.7017
1.86 %
$ 6.46 M
Market Cap
-0.2
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Biofrontera Inc.
| Revenue | 37.3 M |
| Cost Of Revenue | 18.6 M |
| Gross Profit | 18.7 M |
| Operating Expenses | 35.9 M |
| Operating Income | -17.2 M |
| Other Expenses | 549 K |
| Net Income | -17.8 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 37.3 | 34.1 | 28.7 | 24.1 | 18.8 | 26.2 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 18.6 | 17.4 | 15.2 | 12.7 | 9.1 | 12.4 |
| Gross Profit | 18.7 | 16.6 | 13.5 | 11.4 | 9.8 | 13.8 |
| OPERATING INCOME | ||||||
| Operating Expenses | 35.9 | 39.3 | 35.9 | 37.2 | 18.1 | 28.7 |
| Selling, General and Administrative Expenses | 33.8 | 39.1 | 35.9 | 37.2 | 18.1 | 28.7 |
| Research and Development Expenses | 2.1 | 77 K | 0 | 0 | 0 | 0 |
| Operating Income | (17.2) | (22.7) | (22.4) | (25.9) | (8.3) | (14.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 2.1 | 0.6 | 0.2 | 0.3 | 2.9 | 2.2 |
| Total Other Income | (0.5) | 2.6 | 18.0 | (12.5) | (2.6) | 4.0 |
| Pre-Tax Income | (17.7) | (20.1) | (0.6) | (37.7) | (10.9) | (10.9) |
| NET INCOME | ||||||
| Tax Provision | 22 K | 14 K | 32 K | 56 K | 64 K | 33 K |
| Net Income | (17.8) | (20.1) | (0.6) | (37.7) | (11.0) | (11.0) |
| EPS | 0.0032 | 13 | 0.61 | 44.1 | 18.9 | 18.1 |